| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
277,430,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Sotera Health is a holding company. Through its subsidiaries, Co. provides sterilization, lab testing and advisory services for the healthcare industry with operations primarily in the Americas, Europe and Asia. Co.'s segments are: Sterigenics, which provide outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and applications markets using three main technologies: gamma irradiation, ethylene oxide processing and E-beam irradiation; Nordion, which provides Cobalt-60 used in the sterilization and irradiation processes; and Nelson Labs, which provides outsourced microbiological and analytical chemistry testing and advisory services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
48,750,000 |
80,876,611 |
80,876,611 |
166,220,974 |
| Total Sell Value |
$763,585,500 |
$1,249,211,806 |
$1,249,211,806 |
$2,147,483,647 |
| Total People Sold |
4 |
5 |
5 |
6 |
| Total Sell Transactions |
5 |
9 |
9 |
18 |
| End Date |
2025-09-14 |
2025-06-13 |
2024-12-13 |
2023-12-14 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Petras Michael B. Jr. |
Chairman & CEO |
• • – |
2025-12-08 |
4 |
S |
$16.45 |
$7,141,011 |
I/I |
(434,104) |
0 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• • – |
2025-12-08 |
4 |
S |
$16.45 |
$5,196,489 |
D/D |
(315,896) |
552,790 |
|
- |
|
| Gtcr Partners Xi/a&c Lp |
|
– • • |
2025-11-10 |
4 |
S |
$15.65 |
$187,812,000 |
I/I |
(12,000,000) |
29,215,301 |
|
- |
|
| Warburg Pincus Partners Gp Llc |
Director |
– • • |
2025-11-10 |
4 |
S |
$15.65 |
$281,718,000 |
I/I |
(18,000,000) |
43,822,952 |
|
- |
|
| Warburg Pincus Partners Ii, L.p. |
Director |
– • – |
2025-11-10 |
4 |
S |
$15.65 |
$281,718,000 |
I/I |
(18,000,000) |
43,822,952 |
|
- |
|
| Warburg Pincus Partners Gp Llc |
Director |
– • • |
2025-09-05 |
4 |
S |
$15.11 |
$181,332,000 |
I/I |
(12,000,000) |
61,822,952 |
|
- |
|
| Warburg Pincus Partners Ii, L.p. |
Director |
– • – |
2025-09-05 |
4 |
S |
$15.11 |
$181,332,000 |
I/I |
(12,000,000) |
61,822,952 |
|
- |
|
| Gtcr Partners Xi/a&c Lp |
|
– • • |
2025-09-05 |
4 |
S |
$15.11 |
$120,888,000 |
I/I |
(8,000,000) |
41,215,301 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2025-08-22 |
4 |
S |
$16.38 |
$2,074,306 |
D/D |
(126,611) |
450,204 |
|
- |
|
| Lyons Jonathan M. |
Sr. Vice President, CFO |
• – – |
2025-08-05 |
4 |
D |
$11.19 |
$128,775 |
D/D |
(11,508) |
189,602 |
|
- |
|
| Flynn Karen |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
39,221 |
|
- |
|
| Wheadon David E. |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
74,912 |
|
- |
|
| Chen Ruoxi |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
80,781 |
|
- |
|
| Mihas Constantine S |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
80,781 |
|
- |
|
| Knauss Robert Brown |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
54,933 |
|
- |
|
| Cunningham Sean Laurence |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
80,781 |
|
- |
|
| Simon Christopher |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
19,132 |
|
- |
|
| Klee Ann R. |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
125,956 |
|
- |
|
| Petrella Vincent K |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
80,781 |
|
- |
|
| Neary James |
|
– • – |
2025-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
19,132 |
80,781 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
48,579 |
576,815 |
|
- |
|
| Dimitrief Alexander |
SVP, General Counsel and Sec. |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
56,053 |
334,725 |
|
- |
|
| Petras Michael B. Jr. |
Chairman & CEO |
• • – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
298,953 |
868,603 |
|
- |
|
| Lyons Jonathan M. |
Sr. Vice President, CFO |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
97,159 |
201,110 |
|
- |
|
| Rutz Michael P |
President of Sterigenics |
• – – |
2025-03-02 |
4 |
D |
$12.47 |
$119,675 |
D/D |
(9,597) |
528,236 |
|
- |
|
134 Records found
|
|
Page 1 of 6 |
|
|
